Cubist Systematic Strategies’s Livent Corporation LTHM Stock Holding History

Cubist Systematic Strategies’s Portfolio LTHM Stock Details LTHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-66,500	Closed	-$1.2M	–	4449
2023 Q4	$1.2M	Buy	66,500 +42,200	+174%	+$658K	0.01%	1913
2023 Q3	$447K	Buy	+24,300	New	+$556K	﹤0.01%	2378
2022 Q4	–	Sell	-13,200	Closed	-$405K	–	4744
2022 Q3	$405K	Buy	+13,200	New	+$370K	﹤0.01%	3324

Other funds holding LTHM

MIM

MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

MLICM

Metropolitan Life Insurance Company (MetLife) New York $328M AUM 9.77% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

ACA

American Capital Advisory Ketchum, Idaho $275M AUM 22.21% 1-Year Est. Return

Cubist Systematic Strategies's LTHM Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of Livent Corporation (LTHM) in Q2 2023, closing a stake of 109,062 shares — an estimated $2.61M sold.

Cubist Systematic Strategies first reported a position in LTHM in Q4 2018 and held it in 16 quarters. The position peaked at $21.5M in Q4 2022. 442 funds tracked by Wall St. Rank hold LTHM as of Q2 2023.

Cubist Systematic Strategies reported no remaining Livent Corporation position as of Q2 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 109,062 Livent Corporation shares in Q2 2023, an estimated $2.61M.
Cubist Systematic Strategies first reported a position in Livent Corporation in Q4 2018 and held it in 16 quarters.
Cubist Systematic Strategies's Livent Corporation position peaked at $21.5M in Q4 2022.
442 funds tracked by Wall St. Rank held Livent Corporation as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.